Pharmacovigilance and Drug Safety Software Market Size, Share & Trends Analysis Report By Deployment Type (On Premise, On Demand), By Functionality (Case Data Collection and Management, Adverse Event Reporting and Analysis, Signal Detection and Other Safety Risk Assessment), By End Use (Healthcare Companies (Pharmaceuticals & Biotechnology Companies), CROs/BPOs or PV service providers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: April 01, 2026 | Author: Debashree B | Format: | Report Code: SR281DR | Pages: 140

Market Segmentation

  1. Pharmacovigilance and Drug Safety Software Market, By Deployment Type 2022-2034 (USD MILLION/ Units)
    1. On Premise
    2. On Demand
  2. Pharmacovigilance and Drug Safety Software Market, By Functionality 2022-2034 (USD MILLION/ Units)
    1. Case Data Collection and Management
    2. Adverse Event Reporting and Analysis
    3. Signal Detection and Other Safety Risk Assessment
  3. Pharmacovigilance and Drug Safety Software Market, By End Use 2022-2034 (USD MILLION/ Units)
    1. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
    2. CROs/BPOs or PV service providers
    3. Others
  4. Regional Pharmacovigilance and Drug Safety Software Market
    1. North America
      1. North America Pharmacovigilance and Drug Safety Software Market By Deployment Type 2022-2034 (USD MILLION/ Units)
        1. On Premise
        2. On Demand
      2. North America Pharmacovigilance and Drug Safety Software Market By Functionality 2022-2034 (USD MILLION/ Units)
        1. Case Data Collection and Management
        2. Adverse Event Reporting and Analysis
        3. Signal Detection and Other Safety Risk Assessment
      3. North America Pharmacovigilance and Drug Safety Software Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        2. CROs/BPOs or PV service providers
        3. Others
      4. U.S.
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      5. Canada
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
    2. Europe
      1. Europe Pharmacovigilance and Drug Safety Software Market By Deployment Type 2022-2034 (USD MILLION/ Units)
        1. On Premise
        2. On Demand
      2. Europe Pharmacovigilance and Drug Safety Software Market By Functionality 2022-2034 (USD MILLION/ Units)
        1. Case Data Collection and Management
        2. Adverse Event Reporting and Analysis
        3. Signal Detection and Other Safety Risk Assessment
      3. Europe Pharmacovigilance and Drug Safety Software Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        2. CROs/BPOs or PV service providers
        3. Others
      4. U.K.
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      5. Germany
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      6. France
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      7. Spain
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      8. Italy
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      9. Russia
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      10. Nordic
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      11. Benelux
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      12. Rest of Europe
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
    3. APAC
      1. APAC Pharmacovigilance and Drug Safety Software Market By Deployment Type 2022-2034 (USD MILLION/ Units)
        1. On Premise
        2. On Demand
      2. APAC Pharmacovigilance and Drug Safety Software Market By Functionality 2022-2034 (USD MILLION/ Units)
        1. Case Data Collection and Management
        2. Adverse Event Reporting and Analysis
        3. Signal Detection and Other Safety Risk Assessment
      3. APAC Pharmacovigilance and Drug Safety Software Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        2. CROs/BPOs or PV service providers
        3. Others
      4. China
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      5. Korea
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      6. Japan
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      7. India
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      8. Australia
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      9. Taiwan
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      10. South East Asia
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      11. Rest of Asia-Pacific
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
    4. Middle East and Africa
      1. Middle East and Africa Pharmacovigilance and Drug Safety Software Market By Deployment Type 2022-2034 (USD MILLION/ Units)
        1. On Premise
        2. On Demand
      2. Middle East and Africa Pharmacovigilance and Drug Safety Software Market By Functionality 2022-2034 (USD MILLION/ Units)
        1. Case Data Collection and Management
        2. Adverse Event Reporting and Analysis
        3. Signal Detection and Other Safety Risk Assessment
      3. Middle East and Africa Pharmacovigilance and Drug Safety Software Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        2. CROs/BPOs or PV service providers
        3. Others
      4. UAE
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      5. Turkey
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      6. Saudi Arabia
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      7. South Africa
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      8. Egypt
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      9. Nigeria
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      10. Rest of MEA
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
    5. LATAM
      1. LATAM Pharmacovigilance and Drug Safety Software Market By Deployment Type 2022-2034 (USD MILLION/ Units)
        1. On Premise
        2. On Demand
      2. LATAM Pharmacovigilance and Drug Safety Software Market By Functionality 2022-2034 (USD MILLION/ Units)
        1. Case Data Collection and Management
        2. Adverse Event Reporting and Analysis
        3. Signal Detection and Other Safety Risk Assessment
      3. LATAM Pharmacovigilance and Drug Safety Software Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        2. CROs/BPOs or PV service providers
        3. Others
      4. Brazil
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      5. Mexico
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      6. Argentina
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      7. Chile
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      8. Colombia
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
      9. Rest of LATAM
        1. On Premise
        2. On Demand
        3. Case Data Collection and Management
        4. Adverse Event Reporting and Analysis
        5. Signal Detection and Other Safety Risk Assessment
        6. Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
        7. CROs/BPOs or PV service providers
        8. Others
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: